comparemela.com

Latest Breaking News On - Johan aschan - Page 1 : comparemela.com

Sri Lanka Resorts of Cinnamon Hotels & Resorts Mark Earth Day with Impactful Eco-Initiatives - Adaderana Biz English

In celebration of Earth Day, Sri Lanka Resorts of Cinnamon Hotels & Resorts conducted a series of impactful initiatives conducted across its eight properties in Sri Lanka, under this year’s global theme of ‘Plastic Vs Planet’. The beach properties of Sri Lanka Resorts, including Cinnamon Bentota Beach, Cinnamon Bey Beruwala, Hikka Tranz by Cinnamon, and.

Palugaswewa
North-central
Sri-lanka
Kandy
Central
Bentota
Southern
Habarana
Palatupana
Hikkaduwa
Bey-beruwala
Mawakada-canal

Gem Sri Lanka Trade Fair from Jan. 11 to 13

Gem Sri Lanka Trade Fair from Jan. 11 to 13
dailynews.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailynews.lk Daily Mail and Mail on Sunday newspapers.

Sri-lanka
Southern-province
Southern
United-states
China
Bentota
Chinese
America
Rizwan-nayeem
Infas-iqbal
Johan-aschan
Jewellery-authority

XNK Therapeutics appoints Dr. Peter Hovstadius as CMO

/PRNewswire/ XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Dr..

Sweden
Stockholm
Uppsala
Uppsala-lan
Huddinge
Johan-liwing
Johan-aschan
Peter-hovstadius
Uppsala-university
Clinical-development-of-the-novel-cyanoguanidine
Novartis
Chief-medical-officer

XNK Therapeutics AB: XNK Therapeutics appoints Dr. Peter Hovstadius as CMO

HUDDINGE, Sweden, Jan. 19, 2023 /PRNewswire/ XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Dr.

Sweden
Stockholm
Uppsala
Uppsala-lan
Huddinge
Kostenloser-wertpapierhandel
Johan-liwing
Johan-aschan
Peter-hovstadius
Uppsala-university
Clinical-development-of-the-novel-cyanoguanidine
Novartis

Positive clinical results of ACP-001 presented at EHA2022

/PRNewswire/ XNK Therapeutics AB ("XNK") today announced that an abstract on the long-term follow-up of the Phase I/II clinical trial ACP-001 with its.

Sweden
Austria
Vienna
Wien
Stockholm
Stephan-meinke
Johan-aschan
Hans-gustaf-ljunggren
Johan-lund
Johan-liwing
Henrik-holmqvist
Evren-alici

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.